Stockreport

PAREXEL: Robust Growth + Low Valuation = Strong Buy [Seeking Alpha]

PAREXEL INTL  (PRXL) 
Last parexel intl earnings: 8/28 06:21 pm Check Earnings Report
US:NASDAQ Investor Relations: parexel.com/etc/ir
PDF Summary Business Overview Developing a new drug - from inception to approval - can take 10-15 years, sometimes as long as 20 years, and cost in excess of $2.5 [Read more]